Morgan Stanley’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48K | Sell |
|
|||||
|
2025
Q1 | $25.8K | Sell |
|
|||||
|
2024
Q4 | $177K | Buy |
|
|||||
|
2024
Q3 | $196K | Buy |
|
|||||
|
2024
Q2 | $53K | Sell |
|
|||||
|
2024
Q1 | $305K | Sell |
|
|||||
|
2023
Q4 | $863K | Buy |
|
|||||
|
2023
Q3 | $166K | Sell |
|
|||||
|
2023
Q2 | $176K | Buy |
|
|||||
|
2023
Q1 | $84.8K | Buy |
|
|||||
|
2022
Q4 | $6.59K | Sell |
|
|||||
|
2022
Q3 | $30K | Sell |
|
|||||
|
2022
Q2 | $45K | Buy |
|
|||||
|
2022
Q1 | $60K | Sell |
|
|||||
|
2021
Q4 | $69K | Sell |
|
|||||
|
2021
Q3 | $153K | Sell |
|
|||||
|
2021
Q2 | $743K | Buy |
|
|||||
|
2021
Q1 | $314K | Sell |
|
|||||
|
2020
Q4 | $347K | Buy |
|
|||||
|
2020
Q3 | $744K | Sell |
|
|||||
|
2020
Q2 | $1.11M | Buy |
|
|||||
|
2020
Q1 | $364K | Sell |
|
|||||
|
2019
Q4 | $1.42M | Buy |
|
|||||
|
2019
Q3 | $192K | Buy |
|
|||||
|
2019
Q2 | $96K | Sell |
|
|||||
|
2019
Q1 | $224K | Buy |
|
|||||
|
2018
Q4 | $93K | Sell |
|
|||||
|
2018
Q3 | $293K | Buy |
|
|||||
|
2018
Q2 | $223K | Buy |
|
|||||
|
2018
Q1 | $196K | Buy |
|
|||||
|
2017
Q4 | $264K | Buy |
|
|||||
|
2017
Q3 | $59K | Buy |
|
|||||
|
2017
Q2 | $53K | Buy |
|